Evaluation of Appropriate Short-Term Mammographic Surveillance in Patients Who Undergo Breast-Conserving Surgery (BCS)

Gunia, Sommer R.; Merrigan, Tricia L.; Poulton, T B; Mamounas, Eleftherios P.

doi:10.1245/s10434-012-2578-x

Cited by 14 publications

(7 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…14 A third study concluded, after looking at their institutional experience, that the rate of ipsilateral breast cancer recurrence was extremely low during the first two years after BCT (two recurrences out of 375 patients), and the addition of interval ipsilateral mammograms at 6 months and 18 months provided no additional clinical benefit. 15 As another consideration, mammography is less sensitive in women with a history of breast cancer [65.4% (95% CI, 61.5-69.0%)], compared to those with no such history [76.5% (95% CI, 71.7-80.7%)]. 16 Sensitivity is also lower within the first five years after primary breast cancer treatment [60.2% (95%CI, 54.7%-65.5%)] compared to after 5 years from treatment [70.8% (95% CI, 65.4%-75.6%)].…”

Section: Discussionmentioning

confidence: 99%

Assessing the impact of frequent mammography after breast cancer treatment from a single-institution retrospective analysis

Spector,

LeVee,

Karlan

et al. 2023

F1000Res

View full text Add to dashboard Cite

Background Despite prior attempts to establish guidelines, many radiologists still recommend frequent (every six month) mammography after breast conserving surgery. Ideally this recommendation would be based on the incremental value (recurrences detected earlier) of non-annual screening, compared to the associated harm (from false positive results leading to patient distress, unnecessary biopsies/procedures and costs). The aim of this study was to analyze the outcomes of performing biannual mammograms at our institution in order to determine if this may provide any additional benefit to annual mammograms. Methods A retrospective analysis of 359 female patients with stage 0-III breast cancer who underwent breast-conservation surgery was performed. Data were obtained on breast cancer characteristics, imaging, pathology, and recurrence rates. Descriptive analyses were subsequently performed. Results A total of 569 6-month and 18-month mammograms were completed after breast-conservation therapy. This led to 22 biopsies, only one of which detected a recurrence (in a high-risk patient who was unable to complete recommended treatment). Conclusions The data suggest that annual surveillance mammography following breast conserving therapy (BCT) is likely sufficient for detection of recurrences, with increased screening leading to increased harm without benefit. More frequent screening should be limited to select high-risk patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Assessing the impact of frequent mammography after breast cancer treatment from a single-institution retrospective analysis

Spector,

LeVee,

Karlan

et al. 2023

F1000Res

View full text Add to dashboard Cite

show abstract

“…Some studies suggest benefit from biannual mammography for 2-5 years following treatment, while other studies and most major treatment guidelines (including ASCO and NCCN) support annual mammography following breast conservation therapy 15, 16. One retrospective study as well as a meta-analysis of surveillance mammography found no benefit to 6-month interval screening mammography while a recent retrospective single institution review suggested benefit from 5 years of biannual mammographic surveillance 12, 17-19.…”

Section: Monitoring Treatment Response In the Adjuvant Settingmentioning

confidence: 99%

Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer

Graham¹,

Shupe²,

Schneble³

et al. 2014

J. Cancer

View full text Add to dashboard Cite

Monitoring response to treatment is a key element in the management of breast cancer that involves several different viewpoints from surgery, radiology, and medical oncology. In the adjuvant setting, appropriate surgical and pathological evaluation guides adjuvant treatment and follow up care focuses on detecting recurrent disease with the intention of improving long term survival. In the neoadjuvant setting, assessing response to chemotherapy prior to surgery to include evaluation for pathologic response can provide prognostic information to help guide follow up care. In the metastatic setting, for those undergoing treatment, it is crucial to determine responders versus non-responders in order to help guide treatment decisions. In this review, we present the current guidelines for monitoring treatment response in the adjuvant, neoadjuvant, and metastatic setting. In addition, we also discuss challenges that are faced in each setting.

show abstract

“…Most researchers agree that regular surveillance mammography in women diagnosed with early stage breast cancer improves long-term outcomes; however, the optimal interval for mammographic follow-up is currently debated. Some studies suggest benefit from biannual mammography in the initial 2-5 years following treatment, while other studies and most major treatment guidelines (including ASCO and NCCN) support annual mammography following breast conservation therapy 6, 46, 47. One retrospective study and a meta-analysis of surveillance mammography found no benefit to semi-annual (6-month interval) screening mammography, while a recent retrospective single-institution review suggests a benefit from 5 years of semiannual mammographic surveillance 6, 48-50.…”

Section: Mammographymentioning

confidence: 99%

“…Multiple independent studies evaluation intermediate to high-risk populations demonstrate that the combination screening mammography with supplemental ultrasound resulted in a higher false-positive rate and a lower positive predictive value when compared to screening mammography alone 6, 46, 47, 56. Furthermore, in-situ cancers are often missed by sonography, and screening ultrasound is time intensive - often requiring direct physician supervision.…”

Section: Ultrasoundmentioning

confidence: 99%

Current Approaches and Challenges in Early Detection of Breast Cancer Recurrence

Schneble¹,

Graham²,

Shupe³

et al. 2014

J. Cancer

View full text Add to dashboard Cite

Early detection of breast cancer recurrence is a key element of follow-up care and surveillance after completion of primary treatment. The goal is to improve survival by detecting and treating recurrent disease while potentially still curable assuming a more effective salvage surgery and treatment. In this review, we present the current guidelines for early detection of recurrent breast cancer in the adjuvant setting. Emphasis is placed on the multidisciplinary approach from surgery, medical oncology, and radiology with a discussion of the challenges faced within each setting.

show abstract

Evaluation of Appropriate Short-Term Mammographic Surveillance in Patients Who Undergo Breast-Conserving Surgery (BCS)

Abstract: Based on our data and the low expected yield of IBTR in the first 2 years, annual mammographic surveillance appears adequate following BCS and interval ipsilateral mammograms at 6 and 18 months do not provide additional clinical benefit.

Cited by 14 publications

References 20 publications

Assessing the impact of frequent mammography after breast cancer treatment from a single-institution retrospective analysis

Assessing the impact of frequent mammography after breast cancer treatment from a single-institution retrospective analysis

Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer

Current Approaches and Challenges in Early Detection of Breast Cancer Recurrence

Contact Info

Product

Resources

About